| 000 | 01844 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514071637.0 | ||
| 264 | 0 | _c20030626 | |
| 008 | 200306s 0 0 eng d | ||
| 022 | _a0016-5085 | ||
| 024 | 7 |
_a10.1016/s0016-5085(03)00382-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVan den Brande, Jan M H | |
| 245 | 0 | 0 |
_aInfliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. _h[electronic resource] |
| 260 |
_bGastroenterology _cJun 2003 |
||
| 300 |
_a1774-85 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xmetabolism |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCaspase 3 |
| 650 | 0 | 4 |
_aCaspases _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aComplement Activation |
| 650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aGranzymes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xmetabolism |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aIntestinal Mucosa _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xmetabolism |
| 650 | 0 | 4 |
_aSerine Endopeptidases _xbiosynthesis |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBraat, Henri | |
| 700 | 1 | _avan den Brink, Gijs R | |
| 700 | 1 | _aVersteeg, Henri H | |
| 700 | 1 | _aBauer, Christiaan A | |
| 700 | 1 | _aHoedemaeker, Inge | |
| 700 | 1 | _avan Montfrans, Catherine | |
| 700 | 1 | _aHommes, Daan W | |
| 700 | 1 | _aPeppelenbosch, Maikel P | |
| 700 | 1 | _avan Deventer, Sander J H | |
| 773 | 0 |
_tGastroenterology _gvol. 124 _gno. 7 _gp. 1774-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0016-5085(03)00382-2 _zAvailable from publisher's website |
| 999 |
_c12590788 _d12590788 |
||